In this study, we show that this synergy is not limited to Mps1 and taxanes, and that alternative approaches to alter MT dynamics (such as MT-destabilizing drugs such as vincristine or Src inhibitors) in combination with SAC inhibition can be used to synergistically target CIN cells by significantly increasing CIN. This evidence concerns the gene SRC and cervical squamous intraepithelial neoplasia.